PARATEK PHARMACEUTICALS INC shareholders Q1 2023

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 65 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

PARATEK PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
FMR LLC 894$2,2700.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 17,405$44,2090.00%
GOLDMAN SACHS GROUP INC 36,773$93,4030.00%
MORGAN STANLEY 316,848$804,7940.00%
Invesco Ltd. 16,051$40,7700.00%
OSAIC HOLDINGS, INC. 5,292$13,4560.00%
Schonfeld Strategic Advisors LLC 13,900$35,3060.00%
BlackRock Inc. 1,067,011$2,710,2070.00%
Bank of New York Mellon Corp 17,893$45,4480.00%
LPL Financial LLC 51,950$131,9530.00%
TWO SIGMA INVESTMENTS, LP 16,640$42,2660.00%
Baird Financial Group, Inc. 35,500$90,1700.00%
Citadel Advisors 18,200$46,2280.00%
Citadel Advisors 9,400$23,8760.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 100$2540.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 75,641$192,1280.00%
HighTower Advisors, LLC 33,000$84,0000.00%
UBS Group AG 10,276$26,1010.00%
JANE STREET GROUP, LLC 39,518$100,3760.00%
VANGUARD GROUP INC 2,228,066$5,659,2870.00%
External links

This page lists PARATEK PHARMACEUTICALS INC's shareholders in Q1 2023. To view PARATEK PHARMACEUTICALS INC's shareholder history, click here.